Because the technology was so complex, MPSS was only performed 'in-house' by Lynx Therapeutics and no DNA sequencing machines were sold to independent laboratories.
Como a tecnoloxía era tan complexa, a MPSS só foi utilizada pola propia Lynx Therapeutics e non se venderon máquinas de secuenciación a laboratorios independentes.